Microemulsions as drug delivery systems to improve the solubility and the bioavailability of poorly water-soluble drugs

被引：144
作者：
He, Cai-Xia [1 ]
He, Zhong-Gui [2 ]
Gao, Jian-Qing [1 ]
机构：
[1] Zhejiang Univ, Inst Pharmaceut, Hangzhou 310058, Zhejiang, Peoples R China
[2] Shenyang Pharmaceut Univ, Sch Pharm, Shenyang 110016, Liaoning, Peoples R China
来源：
EXPERT OPINION ON DRUG DELIVERY | 2010年 / 7卷 / 04期
关键词：
INTESTINAL LYMPHATIC TRANSPORT; IN-VITRO LIPOLYSIS; CHOLESTEROL-RICH MICROEMULSION; ORAL BIOAVAILABILITY; FORMULATION DEVELOPMENT; P-GLYCOPROTEIN; NANO-EMULSION; MEDIUM-CHAIN; GASTROINTESTINAL-TRACT; TRANSDERMAL DELIVERY;
D O I：
10.1517/17425241003596337
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Areas covered in this review: In this paper, the use and the characteristics of microemulsions as drug delivery vehicles are reviewed. As the formulations of the microemulsion always include a great amount of surfactant and co-surfactant, which may cause hemolysis or histopathological alterations of the tissue, the potential toxicity or the irritancy of microemulsions is also discussed in this paper. What the reader will gain: Developments of microemulsions for poorly water-soluble drugs in recent years are included in this review. Several factors limiting the commercial or clinical use of microemulsions are also discussed. Take home message: Considering the potential in enhanced drug uptake/permeation and facing the limitations, their unique properties make microemulsions a promising vehicle for poorly water-soluble drugs.
引用
收藏
页码：445 / 460
页数：16
相关论文
共 105 条
[1]  
[Anonymous], CURR DRUG THER
[2]  
Anton N, 2008, J CONTROL RELEASE, V128, P185, DOI 10.1016/j.jconrel.2008.02.007
[3]   In vitro studies of the hemolytic activity of microemulsions in human erythrocytes [J].
Aparicio, RM ;
García-Celma, MJ ;
Vinardell, MP ;
Mitjans, M .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2005, 39 (05) :1063-1067
[4]   Plasma kinetics and uptake by the tumor of a cholesterol-rich microemulsion (LDE) associated to etoposide oleate in patients with ovarian carcinoma [J].
Azevedo, CHM ;
Carvalho, JP ;
Valduga, CJ ;
Maranhao, RC .
GYNECOLOGIC ONCOLOGY, 2005, 97 (01) :178-182
[5]   Pluronic block copolymers: Evolution of drug delivery concept from inert nanocarriers to biological response modifiers [J].
Batrakova, Elena V. ;
Kabanov, Alexander V. .
JOURNAL OF CONTROLLED RELEASE, 2008, 130 (02) :98-106
[6]   The advantage of polymer addition to a non-ionic oil in water microemulsion for the dermal delivery of progesterone [J].
Biruss, Babette ;
Valenta, Claudia .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2008, 349 (1-2) :269-273
[7]   Nano-emulsion formulation using spontaneous emulsification:: solvent, oil and surfactant optimisation [J].
Bouchemal, K ;
Briançon, S ;
Perrier, E ;
Fessi, H .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2004, 280 (1-2) :241-251
[8]   Melt extrusion: from process to drug delivery technology [J].
Breitenbach, J .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2002, 54 (02) :107-117
[9]  
Caliph SM, 2000, J PHARM SCI, V89, P1073, DOI 10.1002/1520-6017(200008)89:8<1073::AID-JPS12>3.0.CO
[10]  
2-V
12345678910